Home
The Biomarker
DxPG80 Kit
Clinical
About Us
Contact
See more
Diagnostic and Therapeutic Follow-up of Multi-Cancers
A French, prospective, observational, monocentric study with longitudinal follow-up, in which 420 patients with 16 different types of cancer are included. The purpose of this study is to evaluate the performance of DxPG80.Lab test for diagnosing and prognosing patients with various types of cancers.
High-grade Glial Tumors Therapeutic Follow-up
A pilot French, prospective, observational, monocentric study with longitudinal follow-up, in which 30 patients with high grade brain tumors are included. The purpose of this study is to evaluate the performance of DxPG80.Lab test to monitor disease progression and treatment response.
Prediction of Early Recurrence of Hepatocellular Carcinoma After Liver Surgery
An Italian, prospective, observational, monocentric study with longitudinal follow-up, in which patients with hepatocellular carcinoma that are planned to receive liver surgery (resection and/or transplantation) will be included. The purpose of this study is to evaluate the effectiveness of DxPG80.Lab test in predicting early recurrence in HCC patients after liver surgery.
Diagnostic value to discriminate MEN1 Patients With or Without Neuroendocrine Tumors
A French prospective, observational, multicentric study to assess the diagnostic performance of hPG80 to discriminate MEN1 patients with or without neuroendocrine tumors (NETs).
Metastatic Neuroendocrine Tumors Therapeutic Follow-up
A prospective, observational, multicentric study conducted in 23 centers in United States to evaluate hPG80 as a biomarker of treatment response.
